{ "items": [ "\n\n
\n \n 20 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n COVID\n \n \n\n \n\n\n
\n \n\n \n \n \nThe CAMS-Oxford Institute (COI) has funded 12 COVID-19 projects aiming to understand immune responses to COVID-19, contributing nearly 100 published research articles to the field. Read about the impact the COI has had on our understanding of COVID-19 pathology and immunology.
\n \n\n\n \n 14 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n COI Events\n \n \n\n \n\n\n
\n \n\n \n \n \nThe CSC student Forum with COI director Prof. Tao Dong was held on 14th December 2022, in the meeting room of the CAMS-Oxford Institute.
\n \n\n\n \n 13 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n CAMS-Oxford Joint Symposiums\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nOn 12th December 2022, the Chinese Academy of Medical Sciences-Oxford University Joint Symposium on \u2018Population Medicine & Public Health\u2019 was held online.
\n \n\n\n \n 1 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n COI Events\n \n \n\n \n\n\n
\n \n\n \n \n \nThe first COI Researcher Network meeting was held at Malmaison Hotel, Oxford, on Tuesday 29th November 2022.
\n \n\n\n \n 21 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Lead\n \n \n\n \n\n\n
\n \n\n \n \n \nInvestigation of the T cell responses against monkeypox virus will be led by Prof. Tao Dong at the CAMS-Oxford Institute and MRC Human Immunology Unit.
\n \n\n\n \n 14 October 2022\n \n
\n\n \n \n \n\n \n \n \nA new bioinformatics suite, named in memory of Dr Ling Felce, was officially opened at the CAMS-Oxford Institute (COI) during a ceremony in her honour last month.
\n \n\n\n \n 29 April 2022\n \n
\n\n \n \n \n\n \n \n \nOxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.
\n \n\n\n \n 1 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID\n \n \n\n \n\n\n
\n \n\n \n \n \nStudy from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
\n \n\n\n \n 30 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n CAMS-Oxford Joint Symposiums\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nOn the morning of 29th June 2021, the symposium \u201cCAMS Oxford Joint Symposium- Clinical Medicine Research Without Borders\u201d was held online, jointly organized by the Chinese Academy of Medical Sciences (CAMS) and CAMS-Oxford Institute (COI), and was attended by 1300 participants including Principal Investigators, researchers and students from Oxford and CAMS.
\n \n\n\n \n 18 December 2020\n \n
\n\n \n\n \n\n \n \n \n \n CAMS-Oxford Joint Symposiums\n \n \n \n \n COVID\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nThe CAMS-COI Joint webinar entitled \u201cCOVID Without Borders-A collaboration to Investigate A New Disease III \u2013 Diagnostic and Treatment for COVID-19\u201d was held online on the morning of November 17th 2020.
\n \n\n\n \n 23 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n COVID\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
\n \n\n\n \n 15 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n CAMS-Oxford Joint Symposiums\n \n \n \n \n COVID\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nThe webinar entitled \u201cCOVID Without Borders: A collaboration to Investigate a New Disease II - Vaccine Research and Development\u201d was held online on 22nd September 2020.
\n \n\n\n \n 21 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n CAMS-Oxford Joint Symposiums\n \n \n \n \n COVID\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nOn the morning of 1st July 2020, the webinar \u201cCOVID Without Borders: A collaboration to Investigate A New Disease\u201d was held online.
\n \n\n\n \n 6 February 2020\n \n
\n\n \n\n \n\n \n \n \n \n COVID\n \n \n\n \n\n\n
\n \n\n \n \n \nThe CAMS Oxford Institute has prioritised funding support in response to the current crisis caused by nCoV 2019, supporting positive actions taken by the Medical Sciences Divisions and University of Oxford.
\n \n\n\n \n 23 December 2019\n \n
\n\n \n \n \n\n \n \n \nDelegates from the Ministry of Science and Technology and Chinese Embassy visited the CAMS Oxford Institute in December 2019.
\n \n\n\n \n 2 December 2019\n \n
\n\n \n \n \n\n \n \n \nThe CSC-CAMS/PUMC Oxford High-level Innovative Talent Scholarships and CSC-NDM Scholarships Interviews were held in Beijing in November 2019, representatives from the University of Oxford, the Chinese Academy of Medical Sciences (CAMS) and the Chinese Scholarship Council (CSC) were present.
\n \n\n\n \n 28 November 2019\n \n
\n\n \n \n \n\n \n \n \nA new research discovered circulating antigen-specific CD103+CD8+ T cells can self-regulate their CD103 expression via production of active TGF\u03b21 and have better TCR signalling and effector function compared to CD103- populations.
\n \n\n\n \n 18 November 2019\n \n
\n\n \n \n \n\n \n \n \nCOI Investigators (Xi Li, Ruozheng Wang are the joint first authors) reported a comprehensive analysis of key immune checkpoint receptors on T cells in 172 treatment-na\u00efve, primary cancer patients from the eight most prevalent types of cancer.
\n \n\n\n \n 22 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n Seminars\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Chinese Academy of Medical Sciences Oxford Institute (COI) - Institute of Medicinal Plant Development (IMPLAD) Joint Symposium was held from September 21st to 22nd in Haikou, Hainan.
\n \n\n\n \n 9 August 2019\n \n
\n\n \n \n \n\n \n \n \nMinister Counsellor Yongli Wang and First Secretary Haiyinh Yuan visited the COI on 9th August 2019.
\n \n\n